Biofrontera Inc.

0.85
-0.04 (-3.95%)
At close: Mar 27, 2025, 3:59 PM
0.87
1.86%
Pre-market: Mar 28, 2025, 07:00 AM EDT

Biofrontera Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue 37.3M 34.07M 28.67M 24.1M 18.85M 26.18M
Cost of Revenue 17.86M 17.44M 15.19M 12.74M 9.07M 12.41M
Gross Profit 19.45M 16.63M 13.49M 11.36M 9.78M 13.77M
Operating Income -17.21M -22.68M -22.38M -25.85M -8.33M -14.92M
Interest Income 30K 132K 175K 16K 28K 25K
Pretax Income -17.74M -20.12M -608K -37.66M -10.92M -10.95M
Net Income -17.76M -20.13M -640K -37.71M -10.99M -10.98M
Selling & General & Admin 33.79M 39.13M 35.87M 37.21M 18.12M 28.7M
Research & Development 2.09M 77K n/a n/a n/a n/a
Other Expenses 794K 100K 33K 689K 1.25M 5.48M
Operating Expenses 36.68M 39.3M 35.87M 37.21M 18.12M 28.7M
Interest Expense 2.11M 600K 195K 344K 2.9M 2.16M
Selling & Marketing Expenses n/a 1.43M 100K 500K n/a n/a
Cost & Expenses 54.53M 56.75M 51.05M 49.95M 27.18M 41.1M
Income Tax 22K 14K 32K 56K 64K 33K
Shares Outstanding (Basic) 5.52B 1.55B 1.06B 855.24M 580M 607M
Shares Outstanding (Diluted) 5.52B 1.55B 1.06B 855.24M 580M 607M
EPS (Basic) -0.00 -13.02 -0.61 -44.1 -18.94 -18.09
EPS (Diluted) -0.00 -13.02 -0.61 -44.1 -18.94 -18.09
EBITDA -14.48M -18.45M 934K -36.76M -7.49M -8.15M
Depreciation & Amortization 1.15M 1.06M 1.17M 540K 562K 667K